{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T05:31:51Z","timestamp":1783143111516,"version":"3.54.6"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,1,21]],"date-time":"2023-01-21T00:00:00Z","timestamp":1674259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,21]],"date-time":"2023-01-21T00:00:00Z","timestamp":1674259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s00277-023-05092-x","type":"journal-article","created":{"date-parts":[[2023,1,21]],"date-time":"2023-01-21T00:04:06Z","timestamp":1674259446000},"page":"393-402","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Altered serum lipid levels are associated with prognosis of diffuse large B cell lymphoma and influenced by utility of rituximab"],"prefix":"10.1007","volume":"102","author":[{"given":"Fei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luo","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HuiJuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanting","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bai","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4913-1610","authenticated-orcid":false,"given":"Weiying","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,21]]},"reference":[{"issue":"5","key":"5092_CR1","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3322\/caac.21565","volume":"69","author":"KD Miller","year":"2019","unstructured":"Miller KD, Nogueira L, Mariotto AB, Rowland JH, Yabroff KR, Alfano CM, Jemal A, Kramer JL, Siegel RL (2019) Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin 69(5):363\u2013385. https:\/\/doi.org\/10.3322\/caac.21565","journal-title":"CA Cancer J Clin"},{"issue":"20","key":"5092_CR2","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zelenetz AD, Jaffe ES (2016) The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127(20):2375\u20132390. https:\/\/doi.org\/10.1182\/blood-2016-01-643569","journal-title":"Blood"},{"issue":"12","key":"5092_CR3","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1182\/blood-2010-03-276246","volume":"116","author":"B Coiffier","year":"2010","unstructured":"Coiffier B, Thieblemont C, Van Den Neste E, Lepeu G, Plantier I, Castaigne S, Lefort S, Marit G, Macro M, Sebban C, Belhadj K, Bordessoule D, Ferm\u00e9 C, Tilly H (2010) Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte. Blood 116(12):2040\u20132045. https:\/\/doi.org\/10.1182\/blood-2010-03-276246","journal-title":"Blood"},{"issue":"22","key":"5092_CR4","doi-asserted-by":"publisher","first-page":"8553","DOI":"10.3390\/ijms21228553","volume":"21","author":"LJ Harris","year":"2020","unstructured":"Harris LJ, Patel K, Martin M (2020) Novel therapies for relapsed or refractory diffuse large B-cell lymphoma. Int J Mol Sci 21(22):8553. https:\/\/doi.org\/10.3390\/ijms21228553","journal-title":"Int J Mol Sci"},{"issue":"5","key":"5092_CR5","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/bjh.15412","volume":"182","author":"C Gisselbrecht","year":"2018","unstructured":"Gisselbrecht C, Van Den Neste E (2018) How I manage patients with relapsed\/refractory diffuse large B cell lymphoma. Br J Haematol 182(5):633\u2013643. https:\/\/doi.org\/10.1111\/bjh.15412","journal-title":"Br J Haematol"},{"issue":"16","key":"5092_CR6","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1182\/blood-2017-03-769620","volume":"130","author":"M Crump","year":"2017","unstructured":"Crump M, Neelapu SS, Farooq U, Van Den Neste E, Kuruvilla J, Westin J, Link BK, Hay A, Cerhan JR, Zhu L, Boussetta S, Feng L, Maurer MJ, Navale L, Wiezorek J, Go WY, Gisselbrecht C (2017) Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study. Blood 130(16):1800\u20131808. https:\/\/doi.org\/10.1182\/blood-2017-03-769620","journal-title":"Blood"},{"issue":"1","key":"5092_CR7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/s0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100(1):57\u201370. https:\/\/doi.org\/10.1016\/s0092-8674(00)81683-9","journal-title":"Cell"},{"issue":"3191","key":"5092_CR8","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1126\/science.123.3191.309","volume":"123","author":"O Warburg","year":"1956","unstructured":"Warburg O (1956) On the origin of cancer cells. Science 123(3191):309\u2013314. https:\/\/doi.org\/10.1126\/science.123.3191.309","journal-title":"Science"},{"issue":"6","key":"5092_CR9","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1242\/dmm.011338","volume":"6","author":"F Baenke","year":"2013","unstructured":"Baenke F, Peck B, Miess H, Schulze A (2013) Hooked on fat: the role of lipid synthesis in cancer metabolism and tumour development. Dis Model Mech 6(6):1353\u20131363. https:\/\/doi.org\/10.1242\/dmm.011338","journal-title":"Dis Model Mech"},{"issue":"3","key":"5092_CR10","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/s0899-9007(99)00266-x","volume":"16","author":"FP Kuhajda","year":"2000","unstructured":"Kuhajda FP (2000) Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology. Nutrition 16(3):202\u2013208. https:\/\/doi.org\/10.1016\/s0899-9007(99)00266-x","journal-title":"Nutrition"},{"issue":"10","key":"5092_CR11","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/nrc2222","volume":"7","author":"JA Menendez","year":"2007","unstructured":"Menendez JA, Lupu R (2007) Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer 7(10):763\u2013777. https:\/\/doi.org\/10.1038\/nrc2222","journal-title":"Nat Rev Cancer"},{"issue":"5765","key":"5092_CR12","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1126\/science.1123248","volume":"311","author":"T Maier","year":"2006","unstructured":"Maier T, Jenni S, Ban N (2006) Architecture of mammalian fatty acid synthase at 4.5 A resolution. Science 311(5765):1258\u20131262. https:\/\/doi.org\/10.1126\/science.1123248","journal-title":"Science"},{"issue":"12","key":"5092_CR13","doi-asserted-by":"publisher","first-page":"5977","DOI":"10.1158\/0008-5472.CAN-05-4673","volume":"66","author":"FP Kuhajda","year":"2006","unstructured":"Kuhajda FP (2006) Fatty acid synthase and cancer: new application of an old pathway. Cancer Res 66(12):5977\u20135980. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-4673","journal-title":"Cancer Res"},{"issue":"6","key":"5092_CR14","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/s0046-8177(97)90177-5","volume":"28","author":"TS Gansler","year":"1997","unstructured":"Gansler TS, Hardman W 3rd, Hunt DA, Schaffel S, Hennigar RA (1997) Increased expression of fatty acid synthase (OA-519) in ovarian neoplasms predicts shorter survival. Hum Pathol 28(6):686\u2013692. https:\/\/doi.org\/10.1016\/s0046-8177(97)90177-5","journal-title":"Hum Pathol"},{"issue":"1","key":"5092_CR15","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ygyno.2003.10.027","volume":"92","author":"V Sebastiani","year":"2004","unstructured":"Sebastiani V, Visca P, Botti C, Santeusanio G, Galati GM, Piccini V, Capezzone de Joannon B, Di Tondo U, Alo PL (2004) Fatty acid synthase is a marker of increased risk of recurrence in endometrial carcinoma. Gynecol Oncol 92(1):101\u2013105. https:\/\/doi.org\/10.1016\/j.ygyno.2003.10.027","journal-title":"Gynecol Oncol"},{"key":"5092_CR16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.4103\/jcar.JCar_15_20","volume":"20","author":"W Khan","year":"2021","unstructured":"Khan W, Augustine D, Rao RS, Patil S, Awan KH, Sowmya SV, Haragannavar VC, Prasad K (2021) Lipid metabolism in cancer: a systematic review. J Carcinog 20:4. https:\/\/doi.org\/10.4103\/jcar.JCar_15_20","journal-title":"J Carcinog"},{"issue":"15","key":"5092_CR17","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1111\/j.1742-4658.2012.08644.x","volume":"279","author":"CR Santos","year":"2012","unstructured":"Santos CR, Schulze A (2012) Lipid metabolism in cancer. FEBS J 279(15):2610\u20132623. https:\/\/doi.org\/10.1111\/j.1742-4658.2012.08644.x","journal-title":"FEBS J"},{"issue":"29","key":"5092_CR18","doi-asserted-by":"publisher","first-page":"11818","DOI":"10.1073\/pnas.1205995109","volume":"109","author":"AP Bhatt","year":"2012","unstructured":"Bhatt AP, Jacobs SR, Freemerman AJ, Makowski L, Rathmell JC, Dittmer DP, Damania B (2012) Dysregulation of fatty acid synthesis and glycolysis in non-Hodgkin lymphoma. Proc Natl Acad Sci U S A 109(29):11818\u201311823. https:\/\/doi.org\/10.1073\/pnas.1205995109","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"5092_CR19","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1038\/leu.2015.43","volume":"29","author":"H Horn","year":"2015","unstructured":"Horn H, Ziepert M, Wartenberg M, Staiger AM, Barth TF, Bernd HW, Feller AC, Klapper W, Stuhlmann-Laeisz C, Hummel M, Stein H, Lenze D, Hartmann S, Hansmann ML, M\u00f6ller P, Cogliatti S, Pfreundschuh M, Tr\u00fcmper L, Loeffler M et al (2015) Different biological risk factors in young poor-prognosis and elderly patients with diffuse large B-cell lymphoma. Leukemia 29(7):1564\u20131570. https:\/\/doi.org\/10.1038\/leu.2015.43","journal-title":"Leukemia"},{"issue":"7","key":"5092_CR20","doi-asserted-by":"publisher","first-page":"e2722","DOI":"10.1371\/journal.pone.0002722","volume":"3","author":"YC Liu","year":"2008","unstructured":"Liu YC, Li F, Handler J, Huang CR, Xiang Y, Neretti N, Sedivy JM, Zeller KI, Dang CV (2008) Global regulation of nucleotide biosynthetic genes by c-Myc. PLoS One 3(7):e2722. https:\/\/doi.org\/10.1371\/journal.pone.0002722","journal-title":"PLoS One"},{"issue":"7239","key":"5092_CR21","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/nature07823","volume":"458","author":"P Gao","year":"2009","unstructured":"Gao P, Tchernyshyov I, Chang TC, Lee YS, Kita K, Ochi T, Zeller KI, De Marzo AM, Van Eyk JE, Mendell JT, Dang CV (2009) c-Myc suppression of miR-23a\/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 458(7239):762\u2013765. https:\/\/doi.org\/10.1038\/nature07823","journal-title":"Nature"},{"issue":"1","key":"5092_CR22","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12967-017-1258-9","volume":"15","author":"M Broecker-Preuss","year":"2017","unstructured":"Broecker-Preuss M, Becher-Boveleth N, Bockisch A, D\u00fchrsen U, M\u00fcller S (2017) Regulation of glucose uptake in lymphoma cell lines by c-MYC- and PI3K-dependent signaling pathways and impact of glycolytic pathways on cell viability. J Transl Med 15(1):158. https:\/\/doi.org\/10.1186\/s12967-017-1258-9","journal-title":"J Transl Med"},{"issue":"29","key":"5092_CR23","doi-asserted-by":"publisher","first-page":"10450","DOI":"10.1073\/pnas.1409778111","volume":"111","author":"LS Eberlin","year":"2014","unstructured":"Eberlin LS, Gabay M, Fan AC, Gouw AM, Tibshirani RJ, Felsher DW, Zare RN (2014) Alteration of the lipid profile in lymphomas induced by MYC overexpression. Proc Natl Acad Sci U S A 111(29):10450\u201310455. https:\/\/doi.org\/10.1073\/pnas.1409778111","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"5092_CR24","doi-asserted-by":"publisher","first-page":"10301","DOI":"10.1021\/acsnano.9b03727","volume":"13","author":"A Singh","year":"2019","unstructured":"Singh A, Nandwana V, Rink JS, Ryoo SR, Chen TH, Allen SD, Scott EA, Gordon LI, Thaxton CS, Dravid VP (2019) Biomimetic magnetic nanostructures: a theranostic platform targeting lipid metabolism and immune response in lymphoma. ACS Nano 13(9):10301\u201310311. https:\/\/doi.org\/10.1021\/acsnano.9b03727","journal-title":"ACS Nano"},{"issue":"7","key":"5092_CR25","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1001\/jama.1987.03390070063024","volume":"257","author":"RW Sherwin","year":"1987","unstructured":"Sherwin RW, Wentworth DN, Cutler JA, Hulley SB, Kuller LH, Stamler J (1987) Serum cholesterol levels and cancer mortality in 361,662 men screened for the Multiple Risk Factor Intervention Trial. JAMA 257(7):943\u2013948","journal-title":"JAMA"},{"issue":"2","key":"5092_CR26","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3803\/EnM.2021.1332","volume":"37","author":"J Kim","year":"2022","unstructured":"Kim J, Kim MK, Baek KH, Song KH, Han K, Kwon HS (2022) Repeated low high-density lipoprotein cholesterol and the risk of thyroid cancer: a nationwide population- based study in Korea. Endocrinol Metab (Seoul) 37(2):303\u2013311. https:\/\/doi.org\/10.3803\/EnM.2021.1332","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"8","key":"5092_CR27","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1136\/gut.2010.225011","volume":"60","author":"FJ van Duijnhoven","year":"2011","unstructured":"van Duijnhoven FJ, Bueno-De-Mesquita HB, Calligaro M, Jenab M, Pischon T, Jansen EH, Frohlich J, Ayyobi A, Overvad K, Toft-Petersen AP, Tjonneland A, Hansen L, Boutron-Ruault MC, Clavel-Chapelon F, Cottet V, Palli D, Tagliabue G, Panico S, Tumino R et al (2011) Blood lipid and lipoprotein concentrations and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition. Gut 60(8):1094\u20131102. https:\/\/doi.org\/10.1136\/gut.2010.225011","journal-title":"Gut"},{"key":"5092_CR28","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.cca.2017.11.039","volume":"477","author":"P Zhou","year":"2018","unstructured":"Zhou P, Li B, Liu B, Chen T, Xiao J (2018) Prognostic role of serum total cholesterol and high-density lipoprotein cholesterol in cancer survivors: a systematic review and meta-analysis. Clin Chim Acta 477:94\u2013104. https:\/\/doi.org\/10.1016\/j.cca.2017.11.039","journal-title":"Clin Chim Acta"},{"issue":"4","key":"5092_CR29","doi-asserted-by":"publisher","first-page":"702","DOI":"10.7150\/jca.22836","volume":"9","author":"H Chang","year":"2018","unstructured":"Chang H, Wei JW, Chen K, Zhang S, Han F, Lu LX, Xiao WW, Gao YH (2018) Apolipoprotein A-I is a prognosticator of nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy. J Cancer 9(4):702\u2013710. https:\/\/doi.org\/10.7150\/jca.22836","journal-title":"J Cancer"},{"issue":"2","key":"5092_CR30","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.tranon.2017.01.006","volume":"10","author":"Q Quan","year":"2017","unstructured":"Quan Q, Huang Y, Chen Q, Qiu H, Hu Q, Rong Y, Li T, Xia L, Zhang B (2017) Impact of serum apolipoprotein A-I on prognosis and bevacizumab efficacy in patients with metastatic colorectal cancer: a propensity score-matched analysis. Transl Oncol 10(2):288\u2013294. https:\/\/doi.org\/10.1016\/j.tranon.2017.01.006","journal-title":"Transl Oncol"},{"key":"5092_CR31","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.breast.2017.01.014","volume":"36","author":"R Pakzad","year":"2017","unstructured":"Pakzad R, Safiri S (2017) The effect of preoperative serum triglycerides and high-density lipoprotein-cholesterol levels on the prognosis of breast cancer: methodological issue. Breast 36:103\u2013104. https:\/\/doi.org\/10.1016\/j.breast.2017.01.014","journal-title":"Breast"},{"issue":"5","key":"5092_CR32","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/0002-9343(82)90543-5","volume":"72","author":"RJ Spiegel","year":"1982","unstructured":"Spiegel RJ, Schaefer EJ, Magrath IT, Edwards BK (1982) Plasma lipid alterations in leukemia and lymphoma. Am J Med 72(5):775\u2013782. https:\/\/doi.org\/10.1016\/0002-9343(82)90543-5","journal-title":"Am J Med"},{"issue":"30","key":"5092_CR33","doi-asserted-by":"publisher","first-page":"e29541","DOI":"10.1097\/MD.0000000000029541","volume":"101","author":"T Matsuo","year":"2022","unstructured":"Matsuo T, Tashiro H, Shirasaki R, Sumiyoshi R, Yamamoto T, Saito S, Matsumoto K, Ooi J, Shirafuji N (2022) Serum high-density lipoprotein cholesterol level has a significant prognostic impact on outcomes of follicular lymphoma patients. Medicine (Baltimore) 101(30):e29541. https:\/\/doi.org\/10.1097\/MD.0000000000029541","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"5092_CR34","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s10552-017-0987-7","volume":"29","author":"SH Alford","year":"2018","unstructured":"Alford SH, Divine G, Chao C, Habel LA, Janakiraman N, Wang Y, Feigelson HS, Scholes D, Roblin D, Epstein MM, Engel L, Havstad S, Wells K, Yood MU, Fortuny J, Johnson CC (2018) Serum cholesterol trajectories in the 10 years prior to lymphoma diagnosis. Cancer causes & control : CCC 29(1):143\u2013156. https:\/\/doi.org\/10.1007\/s10552-017-0987-7","journal-title":"Cancer causes & control : CCC"},{"issue":"2","key":"5092_CR35","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/nrm2336","volume":"9","author":"E Ikonen","year":"2008","unstructured":"Ikonen E (2008) Cellular cholesterol trafficking and compartmentalization. Nat Rev Mol Cell Biol 9(2):125\u2013138. https:\/\/doi.org\/10.1038\/nrm2336","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"5092_CR36","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1093\/annonc\/mdn736","volume":"20","author":"AM Strasak","year":"2009","unstructured":"Strasak AM, Pfeiffer RM, Brant LJ, Rapp K, Hilbe W, Oberaigner W, Lang S, Borena W, Concin H, Diem G, Ruttmann E, Glodny B, Pfeiffer KP, Ulmer H (2009) Time-dependent association of total serum cholesterol and cancer incidence in a cohort of 172,210 men and women: a prospective 19-year follow-up study. Ann Oncol 20(6):1113\u20131120. https:\/\/doi.org\/10.1093\/annonc\/mdn736","journal-title":"Ann Oncol"},{"issue":"11","key":"5092_CR37","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1158\/1055-9965.Epi-14-0458","volume":"23","author":"EH Allott","year":"2014","unstructured":"Allott EH, Howard LE, Cooperberg MR, Kane CJ, Aronson WJ, Terris MK, Amling CL, Freedland SJ (2014) Serum lipid profile and risk of prostate cancer recurrence: results from the SEARCH database. Cancer Epidemiol Biomarkers Prev 23(11):2349\u20132356. https:\/\/doi.org\/10.1158\/1055-9965.Epi-14-0458","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"28","key":"5092_CR38","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.1200\/jco.2013.54.4569","volume":"32","author":"CR Cardwell","year":"2014","unstructured":"Cardwell CR, Hicks BM, Hughes C, Murray LJ (2014) Statin use after colorectal cancer diagnosis and survival: a population-based cohort study. J Clin Oncol 32(28):3177\u20133183. https:\/\/doi.org\/10.1200\/jco.2013.54.4569","journal-title":"J Clin Oncol"},{"issue":"19","key":"5092_CR39","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1056\/NEJMoa1201735","volume":"367","author":"SF Nielsen","year":"2012","unstructured":"Nielsen SF, Nordestgaard BG, Bojesen SE (2012) Statin use and reduced cancer-related mortality. N Engl J Med 367(19):1792\u20131802. https:\/\/doi.org\/10.1056\/NEJMoa1201735","journal-title":"N Engl J Med"},{"issue":"12","key":"5092_CR40","doi-asserted-by":"publisher","first-page":"e1098","DOI":"10.1002\/cti2.1098","volume":"8","author":"G Pernes","year":"2019","unstructured":"Pernes G, Flynn MC, Lancaster GI, Murphy AJ (2019) Fat for fuel: lipid metabolism in haematopoiesis. Clin Transl Immunology 8(12):e1098. https:\/\/doi.org\/10.1002\/cti2.1098","journal-title":"Clin Transl Immunology"},{"issue":"3","key":"5092_CR41","doi-asserted-by":"publisher","first-page":"465","DOI":"10.2478\/s11658-008-0014-9","volume":"13","author":"M Kuliszkiewicz-Janus","year":"2008","unstructured":"Kuliszkiewicz-Janus M, Ma\u0142ecki R, Mohamed AS (2008) Lipid changes occuring in the course of hematological cancers. Cell Mol Biol Lett 13(3):465\u2013474. https:\/\/doi.org\/10.2478\/s11658-008-0014-9","journal-title":"Cell Mol Biol Lett"},{"issue":"10","key":"5092_CR42","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1007\/s00277-012-1489-z","volume":"91","author":"G Nagel","year":"2012","unstructured":"Nagel G, Stocks T, Sp\u00e4th D, Hjart\u00e5ker A, Lindkvist B, Hallmans G, Jonsson H, Bj\u00f8rge T, Manjer J, H\u00e4ggstr\u00f6m C, Engeland A, Ulmer H, Selmer R, Concin H, Stattin P, Schlenk RF (2012) Metabolic factors and blood cancers among 578,000 adults in the metabolic syndrome and cancer project (Me-Can). Ann Hematol 91(10):1519\u20131531. https:\/\/doi.org\/10.1007\/s00277-012-1489-z","journal-title":"Ann Hematol"},{"issue":"5","key":"5092_CR43","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1038\/s41375-020-01081-5","volume":"35","author":"SM Jeong","year":"2021","unstructured":"Jeong SM, Choi T, Kim D, Han K, Kim SJ, Rhee SY, Giovannucci EL, Shin DW (2021) Association between high-density lipoprotein cholesterol level and risk of hematologic malignancy. Leukemia 35(5):1356\u20131364. https:\/\/doi.org\/10.1038\/s41375-020-01081-5","journal-title":"Leukemia"},{"issue":"11","key":"5092_CR44","doi-asserted-by":"publisher","first-page":"5569","DOI":"10.1158\/0008-5472.Can-07-0212","volume":"67","author":"U Lim","year":"2007","unstructured":"Lim U, Gayles T, Katki HA, Stolzenberg-Solomon R, Weinstein SJ, Pietinen P, Taylor PR, Virtamo J, Albanes D (2007) Serum high-density lipoprotein cholesterol and risk of non-Hodgkin lymphoma. Cancer Res 67(11):5569\u20135574. https:\/\/doi.org\/10.1158\/0008-5472.Can-07-0212","journal-title":"Cancer Res"},{"issue":"5","key":"5092_CR45","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.chembiol.2019.01.008","volume":"26","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Tan H, Daniels JD, Zandkarimi F, Liu H, Brown LM, Uchida K, O'Connor OA, Stockwell BR (2019) Imidazole ketone erastin induces ferroptosis and slows tumor growth in a mouse lymphoma model. Cell Chem Biol 26(5):623\u2013633.e629. https:\/\/doi.org\/10.1016\/j.chembiol.2019.01.008","journal-title":"Cell Chem Biol"},{"issue":"5","key":"5092_CR46","doi-asserted-by":"publisher","first-page":"e001267","DOI":"10.1161\/JAHA.114.001267","volume":"3","author":"PY Hsue","year":"2014","unstructured":"Hsue PY, Scherzer R, Grunfeld C, Imboden J, Wu Y, Del Puerto G, Nitta E, Shigenaga J, Schnell Heringer A, Ganz P, Graf J (2014) Depletion of B-cells with rituximab improves endothelial function and reduces inflammation among individuals with rheumatoid arthritis. J Am Heart Assoc 3(5):e001267. https:\/\/doi.org\/10.1161\/JAHA.114.001267","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"5092_CR47","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.cmet.2013.05.017","volume":"18","author":"E Currie","year":"2013","unstructured":"Currie E, Schulze A, Zechner R, Walther TC, Farese RV Jr (2013) Cellular fatty acid metabolism and cancer. Cell Metab 18(2):153\u2013161. https:\/\/doi.org\/10.1016\/j.cmet.2013.05.017","journal-title":"Cell Metab"},{"issue":"6","key":"5092_CR48","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.ccr.2013.05.002","volume":"23","author":"L Chen","year":"2013","unstructured":"Chen L, Monti S, Juszczynski P, Ouyang J, Chapuy B, Neuberg D, Doench JG, Bogusz AM, Habermann TM, Dogan A, Witzig TE, Kutok JL, Rodig SJ, Golub T, Shipp MA (2013) SYK inhibition modulates distinct PI3K\/AKT- dependent survival pathways and cholesterol biosynthesis in diffuse large B cell lymphomas. Cancer Cell 23(6):826\u2013838. https:\/\/doi.org\/10.1016\/j.ccr.2013.05.002","journal-title":"Cancer Cell"},{"key":"5092_CR49","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/2162-3619-3-24","volume":"3","author":"I Benakanakere","year":"2014","unstructured":"Benakanakere I, Johnson T, Sleightholm R, Villeda V, Arya M, Bobba R, Freter C, Huang C (2014) Targeting cholesterol synthesis increases chemoimmuno-sensitivity in chronic lymphocytic leukemia cells. Exp Hematol Oncol 3:24. https:\/\/doi.org\/10.1186\/2162-3619-3-24","journal-title":"Exp Hematol Oncol"},{"issue":"2","key":"5092_CR50","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1365-2567.2005.02213.x","volume":"116","author":"TL Unruh","year":"2005","unstructured":"Unruh TL, Li H, Mutch CM, Shariat N, Grigoriou L, Sanyal R, Brown CB, Deans JP (2005) Cholesterol depletion inhibits src family kinase-dependent calcium mobilization and apoptosis induced by rituximab crosslinking. Immunology 116(2):223\u2013232. https:\/\/doi.org\/10.1111\/j.1365-2567.2005.02213.x","journal-title":"Immunology"},{"issue":"3","key":"5092_CR51","doi-asserted-by":"publisher","first-page":"e64","DOI":"10.1371\/journal.pmed.0050064","volume":"5","author":"M Winiarska","year":"2008","unstructured":"Winiarska M, Bil J, Wilczek E, Wilczynski GM, Lekka M, Engelberts PJ, Mackus WJ, Gorska E, Bojarski L, Stoklosa T, Nowis D, Kurzaj Z, Makowski M, Glodkowska E, Issat T, Mrowka P, Lasek W, Dabrowska-Iwanicka A, Basak GW et al (2008) Statins impair antitumor effects of rituximab by inducing conformational changes of CD20. PLoS Med 5(3):e64. https:\/\/doi.org\/10.1371\/journal.pmed.0050064","journal-title":"PLoS Med"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05092-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-023-05092-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05092-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T09:11:48Z","timestamp":1675156308000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-023-05092-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,21]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["5092"],"URL":"https:\/\/doi.org\/10.1007\/s00277-023-05092-x","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,21]]},"assertion":[{"value":"30 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Third Affiliated Hospital of Soochow University","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}